ARC provides patients and healthcare professionals with the latest, up-to-date resources to
help improve treatment and care of patients with amyloidosis.
Guidance for Industry AL Amyloidosis – Developing Drugs for Industry
Developing the guidance involved active participation from all stakeholder groups including patients, medical experts, academics and biopharmaceutical industry representatives. This guidance has been submitted to FDA.Download
ARC Clinical Resources APP
Learn how this valuable tool developed by ARC is giving healthcare professionals easy access to critical and current medical information and improving diagnosis.Visit Website